TerminatedEarly Phase 1NCT02212574
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Principal Investigator
- Kenneth Cohen, MDJohns Hopkins University
- Intervention
- Lomustine(drug)
- Enrollment
- 6 target
- Eligibility
- 3-18 years · All sexes
- Timeline
- 2017 – 2018
Study locations (16)
- Phoenix Childrens Hospital Hematology/Oncology, Phoenix, Arizona, United States
- Children's Hospital Colorado Center for Cancer & Blood Disorders, Aurora, Colorado, United States
- M D Anderson Cancer Center-Orlando Pediatric Hematology/Oncology, Orlando, Florida, United States
- All Children's Hospital Pediatric Hematology/Oncology, St. Petersburg, Florida, United States
- Children's Healthcare of Atlanta- Egleston Pediatric Neuro-Oncology, Atlanta, Georgia, United States
- Ann and Robert H Lurie Children's Hospital of Chicago Hematology/Oncology, Chicago, Illinois, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- Washington University School of Medicine Pediatric Hematology/Oncology, St Louis, Missouri, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- Oregon Health and Science University Pediatric Hematology/Oncology, Portland, Oregon, United States
- Seattle Children's Hospital Hematology/Oncology, Seattle, Washington, United States
- +1 more locations on ClinicalTrials.gov
Collaborators
The Matthew Larson Foundation for Pediatric Brain Tumors
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02212574 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT06701812Digoxin Medulloblastoma StudyH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS